Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 2456179, 7 pages
http://dx.doi.org/10.1155/2016/2456179
Research Article

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases

1Department of General Pathomorphology, Medical University of Bialystok, Waszyngtona Street 13, 15-269 Bialystok, Poland
2Department of Rehabilitation, Medical University of Bialystok, Bialystok, Poland
3Department of Developmental Age Medicine and Paediatric Nursing, Medical University of Bialystok, Bialystok, Poland
4Department of Oncological Surgery, Comprehensive Cancer Centre, Bialystok, Poland

Received 7 September 2015; Revised 21 December 2015; Accepted 27 January 2016

Academic Editor: Helieh Oz

Copyright © 2016 Katarzyna Jakubowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. N. Ananthakrishnan, “Epidemiology and risk factors for IBD,” Nature Reviews Gastroenterology & Hepatology, vol. 12, no. 4, pp. 205–217, 2015. View at Publisher · View at Google Scholar
  2. T. C. DeRoche, S.-Y. Xiao, and X. Liu, “Histological evaluation in ulcerative colitis,” Gastroenterology Report, vol. 2, no. 3, pp. 178–192, 2014. View at Publisher · View at Google Scholar
  3. G. Soucy, H. H. Wang, F. A. Farraye et al., “Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features,” Modern Pathology, vol. 25, no. 2, pp. 295–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Shapiro, “Matrix metalloproteinase degradation of extracellular matrix: biological consequences,” Current Opinion in Cell Biology, vol. 10, no. 5, pp. 602–608, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Nagaset and J. F. Woessner Jr., “Matrix metalloproteinases,” The Journal of Biological Chemistry, vol. 274, no. 31, pp. 21491–21494, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Duarte, J. Baber, T. Fujii, and A. J. Coito, “Matrix metalloproteinases in liver injury, repair and fibrosis,” Matrix Biology, vol. 44–46, pp. 147–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. T. P. Vacek, S. Rahman, S. Yu, D. Neamtu, S. Givimani, and S. C. Tyagi, “Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms,” Vascular Health and Risk Management, vol. 11, pp. 173–183, 2015. View at Publisher · View at Google Scholar
  8. L. Yadav, N. Puri, V. Rastogi, P. Satpute, R. Ahmad, and G. Kaur, “Matrix metalloproteinases and cancer—roles in threat and therapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1085–1091, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Trojanek, “Matrix metalloproteinases and their tissue inhibitors,” Postepy Biochemii, vol. 58, no. 3, pp. 353–362, 2012. View at Google Scholar · View at Scopus
  10. F. Loechel, J. W. Fox, G. Murphy, R. Albrechtsen, and U. M. Wewer, “ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3,” Biochemical and Biophysical Research Communications, vol. 278, no. 3, pp. 511–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Geboes, R. Riddell, A. Öst, B. Jensfelt, T. Persson, and R. Löfberg, “A reproducible grading scale for histological assessment of inflammation in ulcerative colitis,” Gut, vol. 47, no. 3, pp. 404–409, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Rath, M. Roderfeld, J. Graf et al., “Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?” Inflammatory Bowel Diseases, vol. 12, no. 11, pp. 1025–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Newell, L. M. Matrisian, and D. K. Driman, “Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis,” Molecular Carcinogenesis, vol. 34, no. 2, pp. 59–63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. von Lampe, B. Barthel, S. E. Coupland, E.-O. Riecken, and S. Rosewicz, “Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease,” Gut, vol. 47, no. 1, pp. 63–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Pirilä, N. S. Ramamurthy, T. Sorsa, T. Salo, J. Hietanen, and P. Maisi, “Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 γ2-chain expression in murine inflammatory bowel disease (ulcerative colitis),” Digestive Diseases and Sciences, vol. 48, no. 1, pp. 93–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. W. H. Sim, J. Wagner, D. J. Cameron, A. G. Catto-Smith, R. F. Bishop, and C. D. Kirkwood, “Expression profile of genes involved in pathogenesis of pediatric Crohn's disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. 6, pp. 1083–1093, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Garg, M. Rojas, A. Ravi et al., “Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis,” The Journal of Immunology, vol. 177, no. 6, pp. 4103–4112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stallmach, C. C. Chan, K.-W. Ecker et al., “Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis,” Gut, vol. 47, no. 3, pp. 415–422, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ohbayashi, “Matrix metalloproteinases in lung diseases,” Current Protein and Peptide Science, vol. 3, no. 4, pp. 409–421, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Bailey, R. M. Hembry, A. Alexander, M. H. Irving, M. E. Grant, and C. A. Shuttleworth, “Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine,” Journal of Clinical Pathology, vol. 47, no. 2, pp. 113–116, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-W. Mao, X.-M. He, H.-Y. Tang, and Y.-D. Wang, “Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats,” World Journal of Gastroenterology, vol. 18, no. 47, pp. 7063–7069, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Ishida, S. Takai, M. Murano et al., “Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis,” Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 2, pp. 422–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Garg, M. Vijay-Kumar, L. Wang, A. T. Gewirtz, D. Merlin, and S. V. Sitaraman, “Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 2, pp. G175–G184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Santana, C. Medina, M. C. Paz-Cabrera et al., “Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice,” World Journal of Gastroenterology, vol. 12, no. 40, pp. 6464–6472, 2006. View at Google Scholar · View at Scopus
  25. F. E. Castaneda, B. Walia, M. Vijay-Kumar et al., “Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP,” Gastroenterology, vol. 129, no. 6, pp. 1991–2008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Gao, M. J. W. Meijer, F. J. G. M. Kubben et al., “Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases,” Digestive and Liver Disease, vol. 37, no. 8, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Medina, S. Videla, A. Radomski et al., “Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 284, no. 1, pp. G116–G122, 2003. View at Google Scholar · View at Scopus
  28. Y. Naito, T. Takagi, M. Kuroda et al., “An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice,” Inflammation Research, vol. 53, no. 9, pp. 462–468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-D. Wang and P.-Y. Yan, “Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis,” World Journal of Gastroenterology, vol. 12, no. 37, pp. 6050–6053, 2006. View at Google Scholar · View at Scopus
  30. L. Mäkitalo, M. Piekkala, M. Ashorn et al., “Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis,” World Journal of Gastroenterology, vol. 18, no. 30, pp. 4028–4036, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Mäkitalo, K.-L. Kolho, R. Karikoski, H. Anthoni, and U. Saarialho-Kere, “Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 45, no. 7-8, pp. 862–871, 2010. View at Publisher · View at Google Scholar · View at Scopus